StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) income statement

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.56−0.19 (-0.38%)

Close on Nov 18, 2026Market cap $10.75BP/E 25.5Yield 0.50%

QIAGEN N.V. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
62.2%
Operating margin
22.3%
Net margin
20.3%
Return on equity, FY2025
11.6%

Financial strength

Current ratio
3.90
Debt to equity
0.44
Debt to assets
26.3%
Cash to current liabilities
163.8%

Valuation

P/E ratio
25.5
Price to sales
5.14
Price to book
2.85
Dividend yield
0.50%

See a number that looks wrong?